# Evaluation of D3 Receptor Occupancy Using FLUORTRIOPRIDE ([18F]FTP) PET/CT

> **NCT02815917** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Pennsylvania** · enrollment: 30 (estimated)

## Conditions studied

- D3 Dopamine Receptor
- Cocaine-dependent
- Healthy Volunteer

## Interventions

- **DRUG:** [18F]FTP PET/CT

## Key facts

- **NCT ID:** NCT02815917
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-06
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02815917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02815917, "Evaluation of D3 Receptor Occupancy Using FLUORTRIOPRIDE ([18F]FTP) PET/CT". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02815917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*